Detailed Information

Cited 15 time in webofscience Cited 15 time in scopus
Metadata Downloads

The Role of Prolyl Hydroxylase Domain Protein (PHD) during Rosiglitazone-induced Adipocyte Differentiation

Authors
Kim, JuyoungKwak, Hyun JeongCha, Ji-YoungJeong, Yun-SeungRhee, Sang DahlCheon, Hyae Gyeong
Issue Date
31-Jan-2014
Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
Keywords
Adipocyte; Adipogenesis; Diabetes; Kruppel-like Factor (KLF); Peroxisome Proliferator-activated Receptor (PPAR); Adipocyte Differentiation; GATA-3; PHD; PPAR; Rosiglitazone
Citation
JOURNAL OF BIOLOGICAL CHEMISTRY, v.289, no.5, pp.2755 - 2764
Journal Title
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume
289
Number
5
Start Page
2755
End Page
2764
URI
https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12885
DOI
10.1074/jbc.M113.493650
ISSN
1083-351X
Abstract
Background: Rosiglitazone, a well known PPAR agonist, stimulates adipocyte differentiation. Results: In C3H10T1/2 cells, rosiglitazone induces prolyl hydroxylase domain proteins 1, 2, and 3, resulting in the degradation of anti-adipogenic proteins such as GATA-3, KLF-2, and TAZ. Conclusion: Three isoforms of the prolyl hydroxylase domain protein play a key role in rosiglitazone-induced adipocyte differentiation. Significance: Novel mechanisms involved in rosiglitazone-induced adipogenesis would provide a better understanding of adipocyte biology. Rosiglitazone, a well known insulin sensitizer, stimulates adipocyte differentiation via the activation of peroxisome proliferator-activated receptor (PPAR). Previous two-dimensional proteomics studies using C3H10T1/2 murine mesenchymal pluripotent stem cells revealed that prolyl hydroxylase domain protein (PHD) levels significantly increased during rosiglitazone-induced adipocyte differentiation (RIAD). In this study, we investigated the functional role played by PHD during RIAD. Three PHD isoforms (PHD1, 2, and 3) were found to be up-regulated in C3H10T1/2 cells during RIAD, whereas PHD knockdown and treatment with PHD inhibitors (dimethyloxalyl glycine or ethyl-3,4-dihydroxybenzoate) blocked RIAD. PHD inhibition was found to be associated with increases in the levels of anti-adipogenic proteins such as GATA-3, KLF-2, and transcriptional coactivator with PDZ binding motif (TAZ), with their reduced ubiquitination, suggesting that PHDs evoke the ubiquitination/proteasomal degradation of anti-adipogenic proteins. On the other hand, MG-132 (a proteasomal inhibitor) prevented the degradation of anti-adipogenic proteins and retarded RIAD. PPAR antagonists (bisphenol A diglycidyl ether or GW9662) blunted the effects of rosiglitazone on PHD regulation. Furthermore, putative PPAR binding sites were identified in the promoter region of PHDs by ChIP-PCR, implying that rosiglitazone may induce PHD up-regulation directly by PPAR activation. Consistent with in vitro results, oral administration of rosiglitazone to ob/ob mice for 2 weeks increased adipose PHD levels and decreased anti-adipogenic protein levels by increasing their ubiquitination. These results suggest that rosiglitazone increases PHD expression in a PPAR-dependent manner and that this leads to the commitment of anti-adipogenic proteins to the ubiquitination-proteasomal pathway and to the subsequent induction of adipocyte differentiation.
Files in This Item
There are no files associated with this item.
Appears in
Collections
의과대학 > 의예과 > 1. Journal Articles
의과대학 > 의학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Cha, Ji Young photo

Cha, Ji Young
College of Medicine (Premedical Course)
Read more

Altmetrics

Total Views & Downloads

BROWSE